European Society for Medical Oncology Advanced Course on Precision Oncology in Oncogene-Addicted NSCLC BRAF, KRAS, Rare EGFR, RET Barcelona 2023
Format: 18 videos + 19 pdfs, size: 1.15 GB
Course Audience: oncologist
Overview:
- Start date 01 Sep 2023
- End date 02 Sep 2023
- Location Barcelona, Spain
Learning objectives
- To understand the biology of specific oncogene addicted NSCLC and the rationale for targeted treatment
- To review the targeted treatment strategies, including current approvals and ongoing trials, in patients with oncogene addicted NSCLC
- To learn about the best current practice regarding testing methodology and get an outlook on future developments
- To improve interdisciplinary collaboration between oncology and pathology by understanding individual challenges in testing and treatment
- To understand health-economical aspects of targeted treatment in NSCLC
Programme (PDF Format)
Session 1 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board (Video MP4 Format)
Session 1 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board (PDF Format)
Session 1 Biology of the Target Biomarker (Function and Roles in Normal and Tumour Tissue Homeostasis) (Video MP4 Format)
Session 1 Biology of the Target Biomarker (Function and Roles in Normal and Tumour Tissue Homeostasis) (PDF Format)
Session 1 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation) (Video MP4 Format)
Session 1 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation) (PDF Format)
Session 1 Update on the Clinical Efficacy of Approved Targeted Agents Formal Indications, Efficacy and Toxicity (Video MP4 Format)
Session 1 Update on the Clinical Efficacy of Approved Targeted Agents Formal Indications, Efficacy and Toxicity (PDF Format)
Session 2 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board (Video MP4 Format)
Session 2 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board (PDF Format)
Session 2 Biology of the Target Biomarker (Function and Roles in Normal and Tumour Tissue Homeostasis) (Video MP4 Format)
Session 2 Biology of the Target Biomarker (Function and Roles in Normal and Tumour Tissue Homeostasis) (PDF Format)
Session 2 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation) (Video MP4 Format)
Session 2 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation) (PDF Format)
Session 2 Update on the Clinical Efficacy of Approved Targeted Agents Formal Indications, Efficacy and Toxicity (Video MP4 Format)
Session 2 Update on the Clinical Efficacy of Approved Targeted Agents Formal Indications, Efficacy and Toxicity (PDF Format)
Session 3 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board (Video MP4 Format)
Session 3 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board (PDF Format)
Session 3 Biology of the Target Biomarker (Function and Roles in Normal and Tumour Tissue Homeostasis) (Video MP4 Format)
Session 3 Biology of the Target Biomarker (Function and Roles in Normal and Tumour Tissue Homeostasis) (PDF Format)
Session 3 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation) (Video MP4 Format)
Session 3 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation) (PDF Format)
Session 3 Update on the Clinical Efficacy of Approved Targeted Agents Formal Indications, Efficacy and Toxicity (Video MP4 Format)
Session 3 Update on the Clinical Efficacy of Approved Targeted Agents Formal Indications, Efficacy and Toxicity (PDF Format)
Session 4 Value Health Economics of Testing and Targeting (incl. MCBS, ESCAT Actionability, RWD) (Video MP4 Format)
Session 4 Value Health Economics of Testing and Targeting (incl. MCBS, ESCAT Actionability, RWD) (PDF Format)
Session 5 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board (Video MP4 Format)
Session 5 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board (PDF Format)
Session 5 Biology of the Target Biomarker (Function and Roles in Normal and Tumour Tissue Homeostasis) (Video MP4 Format)
Session 5 Biology of the Target Biomarker (Function and Roles in Normal and Tumour Tissue Homeostasis) (PDF Format)
Session 5 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation) (Video MP4 Format)
Session 5 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation) (PDF Format)
Session 5 Update on the Clinical Efficacy of Approved Targeted Agents Formal Indications, Efficacy and Toxicity (Video MP4 Format)
Session 5 Update on the Clinical Efficacy of Approved Targeted Agents Formal Indications, Efficacy and Toxicity (PDF Format)
Welcome and Learning Objectives Introduction (Video MP4 Format)
Welcome and Learning Objectives Introduction (PDF Format)